Showing 2121-2130 of 7006 results for "".
How to Mitigate the Risk of Medical Malpractice Claims
https://reachmd.com/programs/gi-insights/how-to-mitigate-the-risk-of-medical-malpractice-claims/13462/How can you mitigate your risk of medical malpractice claims in the GI field? Here’s what clinicians need to know.Can Canines Sniff Out Cancer?
https://reachmd.com/programs/clinicians-roundtable/can-canines-sniff-out-cancer/10874/You know what they say: dogs are an oncologist’s best friend, especially after a recent study found that 97 percent of them can detect lung cancer.The Alarming Risks of Depression and Suicide for Gay and Bisexual Men
https://reachmd.com/programs/world-medical-news/alarming-risks-depression-and-suicide-gay-and-bisexual-men/8232/Research from the UK found that the risk of suicide attempts is six times higher among young gay and bisexual men.Leadoff Hitter – Spotting High-Risk Players
https://reachmd.com/programs/cme/leadoff-hitter-spotting-high-risk-players/56435/Step up to the plate with evidence-based strategies to identify patients with high-risk ASCVD, optimize LDL-C, and up your game in secondary prevention.TROP2-Directed ADCs in Lung Cancer
https://reachmd.com/programs/cme/trop2-directed-adcs-in-lung-cancer/13887/Rapid-fire approvals of ADCs for a variety of solid tumors now present a clinical conundrum when managing adverse events. Brush up on your knowledge!ADAPT AF-DES: Antithrombotic Strategies Beyond 12 Months for Patients With AF Treated With Drug-Eluting-Stents
https://reachmd.com/clinical-practice/cardiology/adapt-af-des-antithrombotic-strategies-beyond-12-months-for-patients-with-af-treated-with-drug-eluting-stents/48694/Will ADAPT AF-DES findings affect your practice? Tune in for antithrombotic management strategies for patients with drug-eluting stents in the setting of AF.HER2-Directed ADCs in Lung Cancer
https://reachmd.com/programs/cme/her2-directed-adcs-in-lung-cancer/13886/Rapid-fire approvals of ADCs for a variety of solid tumors now present a clinical conundrum when managing adverse events. Brush up on your knowledge!HER3-Directed ADCs in Breast Cancer
https://reachmd.com/programs/cme/her3-directed-adcs-in-breast-cancer/13885/Rapid-fire approvals of ADCs for a variety of solid tumors now present a clinical conundrum when managing adverse events. Brush up on your knowledge!HER3-Directed ADCs in Lung Cancer
https://reachmd.com/programs/cme/her3-directed-adcs-in-lung-cancer/13888/Rapid-fire approvals of ADCs for a variety of solid tumors now present a clinical conundrum when managing adverse events. Brush up on your knowledge!TROP2-Directed ADCs in Bladder Cancer
https://reachmd.com/programs/cme/trop2-directed-adcs-in-bladder-cancer/13891/Rapid-fire approvals of ADCs for a variety of solid tumors now present a clinical conundrum when managing adverse events. Brush up on your knowledge!